Answers are grounded in this paper and cite their sources.
Review outlines mechanisms of secondary differentiation in Chlamydia trachomatis, suggesting implications for pathogenesis.
Chlamydia trachomatis is a gram-negative obligate intracellular pathogenic bacterium that is a leading cause of sexually transmitted and ocular infections. Pathogenic Chlamydia species have a distinct, essential, and tightly controlled biphasic developmental cycle. The non-replicative elementary body (EB) infects a cell and undergoes primary differentiation to the non-infectious reticulate body (RB), which undergoes multiple rounds of division. The shift from the replicative RB form to its infectious EB form, known as secondary differentiation, is a crucial step in this cycle and occurs asynchronously during later stages of development. This process is essential for the pathogen’s ability to spread between host cells and to be transmitted between hosts. Although its importance is clear, the molecular mechanisms behind this key transition are not well understood. In this review, we outline the current knowledge of how C. trachomatis transitions from the RB to the EB. We focus on aspects of secondary differentiation where significant mechanistic insights have been uncovered. Emerging evidence suggests that secondary differentiation is regulated by a network of noncanonical pathways, including controlled proteolysis, redox-dependent signaling, cyclic di-AMP, ATP sensing, and sigma factor-mediated transcription. This review examines the cellular and molecular cues that drive secondary differentiation in C. trachomatis and discusses their implications for pathogenesis and potential treatments. The goal is to provide a current and comprehensive overview of secondary differentiation and its role in understanding chlamydial disease.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: